Multiple Manufacturers

AMBISOME

Manufacturer:

Multiple Manufacturers

Ambisome HCPCS:

J0289

HCPCS Code Descriptor:

Injection, amphotericin b liposome, 10 mg

Category:

J Code

Ambisome NDCs:

00469-3051-30, 55150-0365-01, 62756-0233-01

Primary Type:

Anti-Fungal

Generic/Specialty Status:

Multi-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Ambisome:

AMBISOME is an Anti-Fungal drug manufactured by Astellas Pharma and administered via the Intravenous route of administration. The J Code: J0289 is aligned to the drug AMBISOME.

Ambisome is an anti-fungal drug used to treat life-threatening fungal infections. The active ingredient amphotericin B binds to the cell membranes of fungal cells, disrupting their structure and function. Ambisome is administered via injection into a vein.

ACCESS PRICING AND MORE BY REGISTERING

J0289 Added Date:

January 1, 2003

J0289 Effective Date:

January 1, 2003

J0289 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Ambisome billing and coding information.
Ambisome patient assistance information can be found through Astellas Pharmaceuticals at the URL: https://www.ambisome.com/
Our team is still working to identify a prescribing information source for AMBISOME
Our team has not yet identified a source of side effects information for AMBISOME. Please check back in a few weeks.